Osaic Holdings
ENVB icon

Osaic Holdings’s Enveric Biosciences ENVB Stock Holding History

Osaic Holdings’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$271 – 7473
2024
Q3 		$271 Hold
3
– – ﹤0.01% 7124
2024
Q2 		$385 Buy
3
+2
+200% +$301 ﹤0.01% 7047
2024
Q1 		$150 Hold
1
– – ﹤0.01% 7001
2023
Q4 		$195 Sell
1
-1
-50% -$307 ﹤0.01% 7045
2023
Q3 		$714 Buy
+2
New +$901 ﹤0.01% 6916
2023
Q2 		– Sell
-1
Closed -$249 – 7487
2023
Q1 		$249 Hold
1
– – ﹤0.01% 7238
2022
Q4 		$0 Buy
+1
New +$553 ﹤0.01% 7248
2022
Q2 		– Hold
0
– -$1K – 7409
2022
Q1 		– Hold
0
– – – 7026
2021
Q4 		– Hold
0
– – – 6740
2021
Q3 		– Hold
0
– – – 6270
2021
Q2 		– Hold
0
– – – 6243
2021
Q1 		– Hold
0
– – – 6357
2020
Q4 		– Hold
0
– – – 5836
2020
Q3 		– Hold
0
– – – 5496

Other funds holding ENVB

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Osaic Holdings's ENVB Position: Q4 2024 in Review

Osaic Holdings sold out of Enveric Biosciences (ENVB) in Q4 2024, closing a stake of 3 shares — an estimated $271 sold.

Osaic Holdings first reported a position in ENVB in Q4 2022 and held it in 7 quarters. The position peaked at $714 in Q3 2023. 14 funds tracked by Wall St. Rank hold ENVB as of Q4 2024.

  • Osaic Holdings reported no remaining Enveric Biosciences position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 3 Enveric Biosciences shares in Q4 2024, an estimated $271.
  • Osaic Holdings first reported a position in Enveric Biosciences in Q4 2022 and held it in 7 quarters.
  • Osaic Holdings's Enveric Biosciences position peaked at $714 in Q3 2023.
  • 14 funds tracked by Wall St. Rank held Enveric Biosciences as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.